The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Comparative evaluation of colistin broth disc elution (CBDE) and broth microdilution (BMD) in clinical isolates of Pseudomonas aeruginosa with special reference to heteroresistance
Open accessAbstract
PURPOSE: Antimicrobial resistance (AMR) in Pseudomonas aeruginosa has been ever-increasing. Among other reasons, colistin resistance might be attributed to limited routine testing by approved methods. Both broth microdilution (BMD) and colistin broth disc elution (CBDE) methods have been advocated, with limited data on the performance of these methods in the Indian settings. This prospective study was conducted to determine colistin resistance in P. aeruginosa, compare the BMD and CBDE methods with special reference to heteroresistance. MATERIALS AND METHODS: A total of 100 isolates of P. aeruginosa from admitted patients were included. Antimicrobial susceptibility testing was done against standard antibiotics by disc diffusion test. Minimum inhibitory concentration (MIC) against polymyxins was studied by BMD and CBDE (for colistin only). Heteroresistance to colistin was studied by population analysis profile (PAP). CBDE and BMD were compared by performance calculations. Discrepancy in results were analyzed based on heteroresistance. RESULTS: Majority of the P. aeruginosa isolates were from pus samples (62, 62 %). Disc diffusion method revealed maximum susceptibility towards aztreonam (74, 74 %) followed by meropenem (68, 68 %) and piperacillin-tazobactam (65, 65 %). Polymyxin B resistance was seen in 6 % (6) while colistin resistance was seen in 9 % (9) isolates by BMD. CBDE revealed 8 % (8) resistance to colistin, having 97 % essential agreement and 95 % categorical agreement with BMD. Further, by PAP analysis, 9 isolates were resistant to colistin which included 9 resistant isolates by BMD. On discrepancy analysis, 1 isolate was found to be heteroresistant to colistin. No heteroresistance was seen in the isolates that were susceptible by all the methods. CONCLUSIONS: Heteroresistance to colistin in P. aeruginosa accounted for the discrepancy in results where CBDE method failed to detect heteroresistant isolate. As heteroresistance is a least studied phenotype, it's exact prevalence should be studied so that challenges in susceptibility testing could be addressed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conventional antifungal susceptibility testing methods, such as broth microdilution and disk diffusion assays, may not detect heteroresistant subpopulations [165,166].”
From Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance (2025) · cites this paper as [166]
Citations
Cites
Mackie and McCartney: Practical medical microbiology
Selwyn, S. (1990) · Journal of Hospital Infection · doi:10.1016/0195-6701(90)90135-b · Cited by 649
Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India.
Wattal, C., Goel, N., Oberoi, J. K., Raveendran, R., Datta, S., & Prasad, K. (2010) · PubMed · Cited by 101
Simner, P. J., Bergman, Y., Trejo, M., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01163-18 · Cited by 97
The highly dynamic nature of bacterial heteroresistance impairs its clinical detection
Pereira, C., Larsson, J., Hjort, K., Elf, J., & Andersson, D. I. (2021) · Communications Biology · doi:10.1038/s42003-021-02052-x · Cited by 91
Humphries, R. M., Green, D. A., Schuetz, A. N., et al. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01269-19 · Cited by 88
Rossi, F., Girardello, R., Cury, A. P., et al. (2016) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2016.09.011 · Cited by 76
Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China
Lin, J., Xu, C., Fang, R., Cao, J., Zhang, X., Zhao, Y., Dong, G., Sun, Y., & Zhou, T. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00556-19 · Cited by 70
Methods to Evaluate Colistin Heteroresistance in Acinetobacter baumannii
Sherman, E. X., Wozniak, J. E., & Weiss, D. S. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9118-1_4 · Cited by 49
An Update of Mobile Colistin Resistance in Non-Fermentative Gram-Negative Bacilli
Khuntayaporn, P., Thirapanmethee, K., & Chomnawang, M. T. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.882236 · Cited by 39
Verification of Antimicrobial Susceptibility Testing Methods: a Practical Approach
Patel, J. B., Sharp, S. E., & Novak-Weekley, S. M. (2013) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2013.06.001 · Cited by 38
Cited by
Sorted by citations
Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance
Su, Y., Li, Y., Yi, Q., Xu, Y., Sun, T., & Li, Y. (2025) · Journal of Fungi · doi:10.3390/jof11020143 · Cited by 18
“Conventional antifungal susceptibility testing methods, such as broth microdilution and disk diffusion assays, may not detect heteroresistant subpopulations [165,166].”
Metadata
- Authors
- Banerjee, T., Adwityama, A., Sharma, S., Mishra, K., Prusti, P., & Maitra, U.
- Affiliations
- Institute of Medical Sciences (IN)
- Banaras Hindu University (IN)
- Corresponding author
- Banerjee, Tuhina
- Venue
- Indian Journal of Medical Microbiology
- Publisher
- Elsevier BV
- Published
- 2024-01
- Volume
- 47
- Pages
- 100494
- ISSN
- 0255-0857 (ISSN-L)
- OpenAlex
- W4387996455
- Cited by
- 4
- References
- 17
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1
- FWCI
- 0.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Indian Journal of Medical Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Keywords
- colistin resistance, Pseudomonas aeruginosa, heteroresistance, broth microdilution, antimicrobial susceptibility testing, population analysis profile, polymyxin B resistance, minimum inhibitory concentration, method comparison, clinical isolates, India, pus samples, aztreonam, meropenem, piperacillin-tazobactam
- MeSH terms
- Anti-Bacterial Agents, Colistin, Humans, Microbial Sensitivity Tests, Polymyxin B, Prospective Studies, Pseudomonas aeruginosa, Pseudomonas Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review